[Retracted] miR‑124‑3p inhibits the viability and motility of glioblastoma multiforme by targeting RhoG

[已撤稿] miR-124-3p 通过靶向 RhoG 抑制多形性胶质母细胞瘤的活力和迁移能力

阅读:3

Abstract

Following the publication of this paper, a concerned reader drew to the Editor's attention that, according to a study published by Kristin Entrop and colleagues in the journal Cell Death & Disease in 2024, an unspecific anti‑Bax antibody (sc‑7480) had been used in the above study, which was shown to bind to an unrelated protein at the correct molecular weight (20‑25 kDa). Furthermore, it also came to light that, for the cell migration and invasion assay data shown in Fig. 8B on p. 10, at least four pairs of data panels were shown to feature overlapping sections, such that data which were intended to show the results of differently performed experiments had apparently been derived from a smaller number of original sources. After having performed an independent review of the data in the Editorial Office, the Editor of International Journal of Molecular Medicine has decided that this paper should be retracted from the Journal on account of a lack of confidence in the presented data. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Molecular Medicine 47: 69, 2021; DOI: 10.3892/ijmm.2021.4902].

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。